Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Publication Type:

Journal Article

Source:

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Volume 26, Issue 30, p.4912-20 (2008)

Keywords:

2008, Adult, Aged, Center-Authored Paper, Clinical Research Division, Disease-Free Survival, Female, Flow Cytometry Core Facility, Follow-Up Studies, Graft vs Host Disease, hematopoietic stem cell transplantation, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Male, Middle Aged, Models, Statistical, Remission Induction, Research Trials Office Core Facility - Biostatistics Service, Risk Assessment, Shared Resources, Survival Rate, Transplantation, Homologous, Treatment Outcome, Whole-Body Irradiation

Abstract:

We reported encouraging early results of allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning in 64 patients who had advanced chronic lymphocytic leukemia (CLL). Here, we have extended the follow-up to a median of 5 years and have included data on an additional 18 patients.